http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2387920-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_642ad4dcf320a5689c9301367dd02abe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3251c7da350af0e4d8dd670ac7c68aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2000-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b21a080dc55ad1eccb6ba7fbc2f4327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_117f23b26c7eb669567a82153f17a2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d813a83fe7dc6fdacf009f64bd298e9
publicationDate 2001-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2387920-A1
titleOfInvention A new use of levosimendan
abstract Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment of sick sinus syndrome and/or sinoatrial conduction disorders.
priorityDate 1999-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729372

Total number of triples: 24.